Table 2

Details of the antenatal characteristics of the 70 pregnancies (74 infants for 70 pregnancies because of 4 twin sets)

n (%)
Adverse events during pregnancy:26 (37%)
 Spotting/bleeding8 (11)
 Placental abruptio6 (9)
 Premature contractions4 (6)
 Chronic HIV infection3 (4)
 HELLP syndrome2 (3)
 Placental chorioangioma1 (2)
 Cervical cerclage1 (2)
 Presence of autoantibodies1 (2)
Maternal CMV Serology (first trimester)
 CMV negative39 (53%)
 CMV immune30 (41%)
 Proven seroconversion during pregnancy1 (1%)
 Unknown maternal status4 (5%)
Drug/medication:21 (30%)
 β-Blocker6 (9)
 Tetrahydrocannabinol4 (6)
 Cocaine3 (4)
 Nicotine3 (4)
 Combivir3 (4)
 Benzodiazepine2 (3)
 Antidepressants2 (3)
 HIV Tritherapy2 (3)
 Valproate1 (2)
 Prednisone1 (2)
 Euthyrox1 (2)
Assisted reproduction:13 (19%)
 In vitro fertilization8 (11)
 Hormonal stimulation4 (6)
Pathological Doppler (Class II or III associated with IUGR)6 (9%)
Total antenatal factors combined44 (63%)
  • CMV, cytomegalovirus; IUGR, intrauterine growth restriction.